Substantial cost savings of ultrasound-based management over magnetic resonance imaging-based management in an inflammatory bowel disease service

References

• Jones GR, Lyons M, Plevris N, et al. IBD prevalence in lothian, Scotland, derived by capture-recapture methodology. Gut. 2019;68(11):1953–1960. doi: 10.1136/gutjnl-2019-318936.
   PubMed Web of Science ®Google Scholar
• Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570–1583. doi: 10.1053/j.gastro.2020.12.031.
   PubMed Web of Science ®Google Scholar
• Kennedy NA, Heap GA, Green HD, et al. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal crohn’s disease: a prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2019;4(5):341–353. doi: 10.1016/S2468-1253(19)30012-3.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110(9):1324–1338. doi: 10.1038/ajg.2015.233.
   PubMed Web of Science ®Google Scholar
• Allocca M, Fiorino G, Furfaro F, et al. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic. Clin Gastroenterol Hepatol. 2020;18(8):1882–1883. doi: 10.1016/j.cgh.2020.04.028.
   PubMed Web of Science ®Google Scholar
• Bai X, Yang H, Qian J. COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice. J Crohns Colitis. 2020;14(10):1494–1495. doi: 10.1093/ecco-jcc/jjaa064.
   PubMed Web of Science ®Google Scholar
• Martin Arranz E, Suarez Ferrer C, García Ramírez L, et al. Management of COVID-19 pandemic in Spanish inflammatory bowel disease units: results from a national survey. Inflamm Bowel Dis. 2020;26(8):1149–1154. doi: 10.1093/ibd/izaa142.
   PubMed Web of Science ®Google Scholar
• Allocca M, Furfaro F, Fiorino G, et al. Point-of-care ultrasound in inflammatory bowel disease. Journal of Crohn’s and Colitis. 2020;2020:1–9.
   Google Scholar
• Taylor SA, Mallett S, Bhatnagar G, et al. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease (METRIC): a multicentre trial. Lancet Gastroenterol Hepatol. 2018;3(8):548–558. doi: 10.1016/S2468-1253(18)30161-4.
   PubMed Web of Science ®Google Scholar
• The Hidden Cost and a Vision for Change Crohn’s and Colitis Care in the UK Acknowledgements IBD UK board members and key contributors. 2021).
   Google Scholar
• Radford SJ, Clarke C, Shinkins B, et al. Clinical utility of small bowel ultrasound assessment of Crohn’s disease in adults: a systematic scoping review. Frontline Gastroenterol. 2022;13(4):280–286. doi: 10.1136/flgastro-2021-101897.
   PubMed Web of Science ®Google Scholar
• Radford SJ, Taylor S, Moran G. Ultrasound use to assess Crohn’s disease in the UK: a survey of british society of gastroenterology inflammatory bowel disease group members. Frontline Gastroenterol. 2022;13(6):471–476. doi: 10.1136/flgastro-2021-102065.
   PubMed Web of Science ®Google Scholar
• Pariente B, Mary J-Y, Danese S, et al. Development of the Lémann index to assess digestive tract damage in patients with Crohn’s disease. Gastroenterology. 2015;148(1):52–63.e3. doi: 10.1053/j.gastro.2014.09.015.
   PubMed Web of Science ®Google Scholar
• Le Berre C, Peyrin-Biroulet L, SPIRIT-IOIBD study group. Selecting end points for disease-Modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD. Gastroenterology. 2021;160(5):1452–1460.e21. doi: 10.1053/j.gastro.2020.10.065.
   PubMed Web of Science ®Google Scholar
• Gilletta C, Lewin M, Bourrier A, et al. Changes in the Lémann index values during the first years of Crohn’s disease. Clin Gastroenterol Hepatol. 2015;13(9):1633–1640.e3. doi: 10.1016/j.cgh.2015.02.041.
   PubMed Web of Science ®Google Scholar
• Bodini G, Giannini EG, De Maria C, et al. Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn’s disease. A study performed using the Lémann index. Dig Liver Dis. 2017;49(2):175–180. doi: 10.1016/j.dld.2016.10.014.
   PubMedGoogle Scholar
• England N. National Tariff Payment System: a consultation notice guidance on the aligned payment and incentive approach2022/2023.
   Google Scholar
• Pariente B, Torres J, Burisch J, et al. Validation and update of the Lémann index to measure cumulative structural bowel damage in Crohn’s disease. Gastroenterology. 2021;161(3):853–864.e13. doi: 10.1053/j.gastro.2021.05.049.
   PubMed Web of Science ®Google Scholar
• Lamb CA, Kennedy NA, Raine T, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106. doi: 10.1136/gutjnl-2019-318484.
   PubMed Web of Science ®Google Scholar
• House of commons health C. Managing the care of people with long–term conditions. Second Report of Session 2014–15. 2014;I:1–89. Ev1-131.
   Google Scholar
• NHS Diagnostic Waiting Times and Activity Data NHS England and NHS Improvement 2 NHS Diagnostic Waiting Times and Activity Data. August 2020 Monthly Report. 2020.
   Google Scholar
• Patient experience in adult NHS services: improving the experience of care for people using adult NHS services Clinical guideline. 2012.
   Google Scholar
• Collins B. Payments and contracting for integrated care The false promise of the self-improving health system2019.
   Google Scholar
• Castle-Clarke S, Edwards N, Buckingham H. Falling short: why the NHS is still struggling to make the most of new innovations2017.
   Google Scholar
• Johnson MJ, May CR. Promoting professional behaviour change in healthcare: what interventions work, and why? A theory-led overview of systematic reviews. BMJ Open. 2015;5(9):e008592-e. doi: 10.1136/bmjopen-2015-008592.
   Web of Science ®Google Scholar
• Hulscher M, Schouten L, Grol R, et al. Determinants of success of quality improvement collaboratives: what does the literature show? BMJ Qual Saf. 2013;22(1):19–31. doi: 10.1136/bmjqs-2011-000651.
   PubMed Web of Science ®Google Scholar
• Wilkens R, Dolinger M, Burisch J, et al. Point-of-care testing and home testing: pragmatic considerations for widespread incorporation of stool tests, serum tests, and intestinal ultrasound. Gastroenterology. 2022;162(5):1476–1492. doi: 10.1053/j.gastro.2021.10.052.
   PubMed Web of Science ®Google Scholar
• Radford S, Leighton P, Coad J, et al. Stakeholder-identified barriers and enablers to ultrasound implementation in inflammatory bowel disease services in the UK: a qualitative interview study. BMJ Open. 2023;13(6):e067528. doi: 10.1136/bmjopen-2022-067528.
   PubMed Web of Science ®Google Scholar
• Clough J, Mawdsley J, Irving P, editors. P95 inflammatory bowel disease diagnosis: choosing the right path. 2021: BMJ Publishing Group Ltd and British Society of Gastroenterology.
   Google Scholar
• Wurcel V, Cicchetti A, Garrison L, et al. The Value of Diagnostic Information in Personalised Healthcare: a Comprehensive Concept to Facilitate Bringing This Technology into Healthcare Systems. 2019.
   Google Scholar
• Marín-Jiménez I, Casellas F, Cortés X, et al. The experience of inflammatory bowel disease patients with healthcare a survey with the IEXPAC instrument. Medicine (Baltimore). 2019;98(14):e15044. doi: 10.1097/MD.0000000000015044.
   PubMed Web of Science ®Google Scholar
• Bryant RV, Friedman AB, Wright EK, et al. Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. BMJ Publishing Group; 2018. p973–985. doi: 10.1136/gutjnl-2017-315655.
   Google Scholar
• Lee DW, Koo JS, Choe JW, et al. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol. 2017;23(35):6474–6481. doi: 10.3748/wjg.v23.i35.6474.
   PubMed Web of Science ®Google Scholar
• Schoepfer AM, Dehlavi MA, Fournier N, et al. Diagnostic delay in crohn’s disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013;108(11):1744–1753; quiz 1754. doi: 10.1038/ajg.2013.248.
   PubMed Web of Science ®Google Scholar
• The Value of Knowing and Knowing the Value: improving the Health Technology Assessment of Complementary Diagnostics. 2016).
   Google Scholar
• Anonychuk A, Beastall G, Shorter S, et al. A framework for assessing the value of laboratory diagnostics. Healthc Manage Forum. 2012;25(3_suppl):S4–S11. doi: 10.1016/j.hcmf.2012.07.015.
   PubMedGoogle Scholar
• Fortney JC, Burgess JF, Bosworth HB, et al. A re-conceptualization of access for 21st century healthcare. J Gen Intern Med. 2011;26 Suppl 2(Suppl 2):639–647. doi: 10.1007/s11606-011-1806-6.
   PubMedGoogle Scholar
• Ghosh N, Premchand P. A UK cost of care model for inflammatory bowel disease. Frontline Gastroenterol. 2015;6(3):169–174. doi: 10.1136/flgastro-2014-100514.
   PubMedGoogle Scholar
• Burisch J, Zhao M, Odes S, et al. The cost of inflammatory bowel disease in high-income settings: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2023;8(5):458–492. doi: 10.1016/S2468-1253(23)00003-1.
   PubMed Web of Science ®Google Scholar
• Ahmed Ali U, Kiran RP. Surgery for crohn’s disease: upfront or last resort? Gastroenterol Rep (Oxf). 2022;10:goac063. doi: 10.1093/gastro/goac063.
   PubMed Web of Science ®Google Scholar
• Farraj KL, Pellegrini JR, Munshi RF, et al. Chronic steroid use: an overlooked impact on patients with inflammatory bowel disease. JGH Open. 2022;6(12):910–914. doi: 10.1002/jgh3.12841.
   PubMed Web of Science ®Google Scholar
• Melmed GY, Siegel CA. Quality improvement in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013;9(5):286–292.
   PubMedGoogle Scholar
• Selinger CP, Parkes GC, Bassi A, et al. A multi-Centre audit of excess steroid use in 1176 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46(10):964–973. doi: 10.1111/apt.14334.
   PubMed Web of Science ®Google Scholar
• Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247(1):64–79. doi: 10.1148/radiol.2471070611.
   PubMed Web of Science ®Google Scholar
• Dong J, Wang H, Zhao J, et al. Ultrasound as a diagnostic tool in detecting active crohn’s disease: a meta-analysis of prospective studies. Eur Radiol. 2014;24(1):26–33. doi: 10.1007/s00330-013-2973-0.
   PubMed Web of Science ®Google Scholar
• Puylaert CAJ, Tielbeek JAW, Bipat S, et al. Grading of crohn’s disease activity using CT, MRI, US and scintigraphy: a meta-analysis. Eur Radiol. 2015;25(11):3295–3313. doi: 10.1007/s00330-015-3737-9.
   PubMed Web of Science ®Google Scholar
• Greenup AJ, Bressler B, Rosenfeld G. Medical imaging in small bowel crohn’s disease - Computer tomography enterography, magnetic resonance enterography, and ultrasound: "which one is the best for what. Inflamm Bowel Dis. 2016;22(5):1246–1261. doi: 10.1097/MIB.0000000000000727.
   PubMed Web of Science ®Google Scholar
• Alshammari MT, Stevenson R, Abdul-Aema B, et al. Diagnostic accuracy of Non-Invasive imaging for detection of colonic inflammation in patients with inflammatory bowel disease: a systematic review and Meta-Analysis. Diagnostics. 20212021;11(10)Page:1926. 111926-. doi: 10.3390/diagnostics11101926.
   Web of Science ®Google Scholar
• Knocke K, Wagner TW. The evolving economics of implementation. BMJ Qual Saf. 2021;31(8):555–557. doi: 10.1136/bmjqs-2021-014411.
   PubMed Web of Science ®Google Scholar
• Wagner TH, Dopp AR, Gold HT. Estimating downstream budget ­impacts in implementation research. Med Decis Making. 2020;40(8):968–977. doi: 10.1177/0272989X20954387.
   PubMed Web of Science ®Google Scholar